Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine in type 2 diabetes induced nephropathy
NCT04531163Phase 3Unknown
- Sponsor
- Al-Azhar University
- Start
- Oct 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in diabetic nephropathy (DN), sponsored by Al-Azhar University. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT04531163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04531163.